Pharmaceutical Resources Wins FDA Approval For Generic Daypro

[Guest guest]

Pharmaceutical Resources Wins FDA Approval For Generic Daypro

WASHINGTON (Reuters Health) Mar 01 - Pharmaceutical Resources Inc. (PRI) on

Thursday said that it has received approval from the US Food and Drug

Administration to market oxaprozin tablets, a generic version of Pharmacia's

osteoarthritis and rheumatoid arthritis drug Daypro.

PRI said that its subsidiary Par Pharmaceuticals would immediately begin

distributing the generic drug. The Spring Valley, New York-based firm said it

co-developed oxaprozin with Merck KgaA.

PRI won FDA approval in mid-February for a generic formulation of Eli Lilly's

anti-psychotic drug Prozac (fluoxetine) 10 mg and 20 mg strengths, which the

company expects to launch around February 2002.